The F.D.A. claimed it could not comment on whether it would assistance ibogaine research in the future, noting that federal regulation prohibits the company from commenting on future investigational drug purposes.Now, for the first time, some upstart pharmaceutical companies, which include ATAI Everyday living Sciences and MindMed, are noticing the